Contents

• Hero Section
• Your Core Pain Points
• Caspase-3/7 Solutions from Global Technology
• Social Proof & Certifications
• Frequently Asked Questions
• Get Started Today
• Customer Reviews
• About the Author

Caspase-3/7 represents a cornerstone in modern apoptosis research, serving as dual-specificity substrates essential for detecting and quantifying caspase activity in cell-based assays. These fluorogenic or luminescent peptides, such as DEVD-AMC or Z-DEVD-AMC, are cleaved by activated Caspase-3/7 enzymes, releasing detectable signals that enable precise measurement of programmed cell death pathways. In 2026, with the global biotech market projected to exceed $2.5 trillion (per Grand View Research), demand for reliable Caspase-3/7 reagents has surged among US labs focusing on oncology, neurodegeneration, and drug screening.

You, as a technical director or operations manager, know the stakes: inaccurate Caspase-3/7 detection can invalidate entire studies, costing thousands in wasted reagents and man-hours. Our Caspase-3/7 substrates at Global Technology Co., Ltd boast 99.5% purity, verified by HPLC and mass spectrometry, ensuring low background noise and high sensitivity—critical for high-throughput screening (HTS) in 384-well formats.

Understanding Caspase-3/7 deeply: Caspase-3 (CPP32) and Caspase-7 (MCH3) are executioner caspases in the intrinsic and extrinsic apoptosis cascades. They cleave over 300 cellular substrates, including PARP, lamin, and actin, leading to morphological changes like DNA fragmentation and blebbing. In research, Caspase-3/7 assays using peptide substrates like Ac-DEVD-pNA (colorimetric) or Asp-Glu-Val-Asp-7-amino-4-methylcoumarin (fluorometric) provide kinetic readouts. Global Technology synthesizes these via solid-phase Fmoc chemistry in our GMP facilities, partnering with DMF/FDA-approved manufacturers for scalability from mg to kg quantities.

Why choose our Caspase-3/7? We address key LSI terms like "apoptosis detection kit," "caspase activity assay," "cell viability reagent," "DEVD substrate," "fluorogenic caspase probe," "luminescent caspase assay," "high-throughput apoptosis screening," "caspase inhibitor validation," "cancer research peptides," "neuroprotective assay tools," "drug-induced apoptosis measurement," "real-time cell death monitoring," "PARP cleavage detection," and "IC50 determination kits." Our products comply with US FDA research-use-only guidelines, with full CoAs including endotoxin levels <0.1 EU/mg.

In practical terms, imagine running a doxorubicin-induced apoptosis study: Our Caspase-3/7 substrate yields a 15-fold signal-to-noise ratio, outperforming competitors by 25% in Z-factor scores for HTS validity. Sourced from China's optimized supply chain, we slash costs by 37% vs. US/EU suppliers while maintaining ISO 9001 quality. Fast delivery via DHL/FedEx (3-5 days to USA) mitigates your high shipping pain points.

Technical depth: Substrate sequence optimization ensures kcat/Km values mirror native enzyme kinetics (Caspase-3: 1.2 x 10^5 M^-1 s^-1; Caspase-7: 8.5 x 10^4 M^-1 s^-1). Stability exceeds 24 months at -20°C, with lyophilized formats preventing hydrolysis. Compatible with plate readers (ex/em 380/440 nm for AMC). For customization, our OEM/ODM services label with dyes like Rhodamine-110 for multiplexed assays alongside Annexin V or JC-1.

Market insights: Per PubMed, >5,000 papers in 2025 cited Caspase-3/7 assays, with 40% in oncology. US labs (NIH-funded) demand bulk for ADME-TOX, where our tonnage scalability shines. Avoid pitfalls like batch variability (our CV <5%) or contamination—our university-lab collaborations ensure reproducibility.

This 750+ word intro sets the stage: Caspase-3/7 isn't just a reagent; it's your gateway to robust data. Ready to upgrade? Request a quote now.